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The Canadian Integrated Program for Antimicrobial Re-
sistance Surveillance describes a strong correlation (r = 0.9, 
p<0.0001) between ceftiofur-resistant Salmonella enterica 
serovar Heidelberg isolated from retail chicken and inci-
dence of ceftiofur-resistant Salmonella serovar Heidelberg 
infections in humans across Canada. In Québec, changes 
of ceftiofur resistance in chicken Salmonella Heidelberg and 
Escherichia coli isolates appear related to changing levels 
of ceftiofur use in hatcheries during the study period, from 
highest to lowest levels before and after a voluntary with-
drawal, to increasing levels after reintroduction of use (62% 
to 7% to 20%, and 34% to 6% to 19%, respectively). These 
events provide evidence that ceftiofur use in chickens 
results in extended-spectrum cephalosporin resistance in 
bacteria from chicken and humans. To ensure the contin-
ued effectiveness of extended-spectrum cephalosporins for 
treating serious infections in humans, multidisciplinary ef-
forts are needed to scrutinize and, where appropriate, limit 
use of ceftiofur in chicken production in Canada. 
S
almonella enterica serovar Heidelberg ranks among 
the top 3 serovars isolated from persons infected with 
Salmonella in Canada (1). It is more frequently reported 
in North America than in other regions of the world (2). 
Although many Salmonella Heidelberg infections result in 
mild to moderate illness, the bacterium also causes severe 
illness with complications such as septicemia, myocardi-
tis, extraintestinal infections, and death (3,4). Salmonella 
Heidelberg appears more invasive than other gastroen-
teritis-causing serovars; ≈9% of isolates of this serovar 
received through the Canadian Integrated Program for 
Antimicrobial Resistance Surveillance (CIPARS) during 
2003–2005 were recovered from blood samples (5). Treat-
ment with antimicrobial agents may be life-saving in the 
case of invasive infections.
Sources of human Salmonella Heidelberg infection 
include consumption of poultry or eggs and egg-contain-
ing products (6–10). In Canada, Salmonella Heidelberg is 
commonly isolated from healthy chickens from farm, abat-
toir, and retail sources (11,12). It also has been isolated, 
although less frequently, from ground beef, pork, and tur-
key meat (13–15) and from clinical samples from various 
animal species (12).
Ceftiofur is an extended-spectrum cephalosporin drug 
approved in Canada for use with numerous label indica-
tions in cattle, swine, horses, sheep, turkeys, dogs, and cats. 
Ceftiofur is also injected in ovo to control Escherichia coli 
omphalitis in broiler chickens; this use is not an approved 
label indication.
A major public health concern is that use of third-gen-
eration cephalosporins, such as ceftiofur, in food animals 
is leading to resistance to other extended-spectrum cepha-
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losporins, such as ceftriaxone and cephamycins (16–20), a 
group of antimicrobial agents used to treat a wide variety 
of human infections. Among other indications, ceftriaxone 
is the drug of choice for treating severe or invasive sal-
monellosis in children and pregnant women (16,17) where 
ﬂ  uoroquinolones are not approved and treatment options 
are limited. Accordingly, third-generation cephalosporins 
have been classiﬁ  ed as Critically Important Antimicrobi-
als in Human Medicine by the World Health Organization 
(21) and as Class 1 Very High Importance in Human Medi-
cine by the Canadian Veterinary Drugs Directorate, Health 
Canada (22).
In Canada, ceftiofur resistance in bacteria from healthy 
animals or food is mainly reported in chicken Salmonella 
Heidelberg isolates originating from farm, abattoir, and 
retail samples and in chicken abattoir and retail generic 
E. coli isolates (11,12). It also is occasionally reported in 
Salmonella isolates from sick animals or in bovine and 
porcine abattoir or retail E. coli isolates but at much lower 
frequency (12).
The objective of this study is to highlight the correla-
tion between ceftiofur-resistant Salmonella Heidelberg iso-
lated from retail chicken and the incidence of ceftiofur-re-
sistant Salmonella Heidelberg infections in humans across 
Canada. Public health concerns raised by publication of the 
CIPARS 2003 annual report, speciﬁ  cally the higher rates of 
ceftiofur resistance in Salmonella Heidelberg isolates from 
chicken meat than from humans, prompted Québec broiler 
chicken hatcheries to voluntarily interrupt the extralabel 
in ovo use of ceftiofur during 2005–2006 (23). This study 
therefore also describes variations in ceftiofur resistance 
among chicken and human Salmonella Heidelberg and 
chicken E. coli strains in that province before, during, and 
after the voluntary withdrawal.
Materials and Methods
CIPARS is a national program led by the Public Health 
Agency of Canada (PHAC) dedicated to the preservation 
of effective antimicrobial drugs for humans and animals 
through the collection, integration, analysis, and commu-
nication of trends in antimicrobial resistance in selected 
bacterial organisms. Data presented here were collected 
during 2003–2008 from CIPARS’ surveillance of human 
clinical Salmonella isolates and E. coli and Salmonella iso-
lates from retail chicken. Detailed methods for sample col-
lection, bacterial isolation, antimicrobial resistance testing, 
and data analysis are described in CIPARS’s reports (12).
Sample Collection
Human Salmonella Isolates
Hospital-based and private clinical laboratories isolated 
and forwarded human Salmonella isolates to their Provin-
cial Public Health Laboratory (PPHL). PPHLs forwarded 
Salmonella isolates to the Enteric Diseases Program, Na-
tional Microbiology Laboratory (NML), PHAC, for phage 
type characterization and antimicrobial resistance testing. 
All isolates (outbreak and nonoutbreak) received passively 
by the Saskatchewan PPHL were forwarded; the more pop-
ulated provinces (British Columbia, Ontario, and Québec) 
forwarded isolates received from days 1–15 of each month. 
Only 1 isolate per patient was kept for the analysis.
Retail Meat Samples
To use a similar geographic scale as CIPARS surveil-
lance of human clinical Salmonella isolates and because 
we expected a certain level of provincial clustering in food 
distribution, we designed the study of CIPARS retail sur-
veillance to provide a representative measurement of what 
consumers from each province were exposed to through 
ingestion of improperly cooked raw meat or cross-contam-
ination. Randomization and weighted allocation of samples 
according to demography of the human population ensured 
that the data generated through retail sampling were rep-
resentative and reliable at the provincial level. Retail raw 
chicken samples (most often chicken thigh with skin on) 
were collected as part of CIPARS retail program that pur-
chases samples weekly (Ontario and Québec) or biweekly 
(Saskatchewan, British Columbia) from chain, indepen-
dent, and butcher stores in 15–18 randomly selected census 
divisions in each participating province. Retail surveillance 
was initiated in Ontario and Québec in mid-2003 and at the 
beginning of 2005 in Saskatchewan. Surveillance also was 
conducted during part of 2007 and all of 2008 in British 
Columbia.
Microbiologic Analysis
Recovery of Isolates from Retail Chicken Meat
Primary isolations of E. coli and Salmonella spp. were 
conducted at the Laboratory for Foodborne Zoonoses, 
PHAC. Every retail chicken meat sample received was cul-
tivated for Salmonella, but only 1 of every 2 samples was 
systematically selected to be tested for generic E. coli iso-
lation. Incubated peptone rinses of chicken meat samples 
were streaked on eosin-methylene blue agar (Becton Dick-
inson, Sparks, MD, USA). Presumptive E. coli colonies 
were identiﬁ  ed by using the Simmons’ citrate and indole 
tests. Colonies showing negative indole results were identi-
ﬁ  ed by using the API 20E (bioMérieux Clinical Diagnos-
tics, Marcy l’Étoile, France). All chicken samples were 
tested for Salmonella with a modiﬁ  ed MFLP-75 method 
of the Compendium of Analytical Methods (24). Incu-
bated peptone rinses were injected into modiﬁ  ed semisolid 
Rappaport-Vassiliadis media. Presumptive E. coli colonies 
were injected into triple sugar iron and urea agar slants 
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and subjected to the indole test. Presumptive Salmonella 
isolates were veriﬁ  ed by slide agglutination using PolyA-I 
and Vi Salmonella antiserum (Difco, Becton Dickinson). 
Salmonella isolates were shipped between laboratories on 
a tryptic soy agar slant by priority courier. No selective me-
dia were used to isolate ceftiofur-resistant bacteria.
Serotyping, Phage Typing, and 
Susceptibility Testing
Human and chicken Salmonella isolates were sero-
typed and phage typed by using published methods (25–28). 
MICs were determined by the NML (human isolates) and 
the Laboratory for Foodborne Zoonoses, PHAC (chicken 
isolates) by the broth microdilution method (Sensititre Au-
tomated Microbiology System; Trek Diagnostic Systems 
Ltd., Westlake, OH, USA). Salmonella and E. coli isolates 
were tested by using the National Antimicrobial Resistance 
Monitoring System custom susceptibility plate for gram-
negative bacteria. The breakpoint used to determine ceftio-
fur resistance was >4 μg/mL (29).
Data Analysis
We analyzed data using SAS version 9.1 (SAS Insti-
tute Inc., Cary, NC, USA). The yearly proportion of retail 
chicken samples contaminated with ceftiofur-resistant Sal-
monella Heidelberg (or E. coli) and the incidence rate of 
human infection with ceftiofur-resistant Salmonella Heidel-
berg was calculated as described in CIPARS 2006 annual 
report (12). The Pearson product-moment correlation was 
used to verify the correlation between ceftiofur-resistant 
Salmonella Heidelberg isolated from retail chicken and hu-
man incidence estimates by using the Pearson option in the 
PROC CORR procedure in SAS. We computed the overall 
correlation coefﬁ  cient using data across all provinces un-
der study and computed a speciﬁ  c coefﬁ  cient for provinces 
with >5 observations (30)
To describe ceftiofur resistance changes by quarter 
and reduce the noise around the estimate caused by the 
small number of observations per quarter, we computed a 
nonweighted rolling average of the prevalence of ceftiofur 
resistance using data from the current quarter and the pre-
vious 2 quarters for chicken E. coli, chicken Salmonella 
Heidelberg, and human Salmonella Heidelberg isolates 
from the province of Québec. We tested differences in ceft-
iofur resistance between years with SAS using χ2 or Fisher 
exact tests when appropriate.
Results
Ceftiofur-Resistant Salmonella Heidelberg Isolated 
from Retail Chickens and from Humans
Across Canada, the annual percentage of chicken 
samples contaminated with ceftiofur-resistant Salmonella 
Heidelberg correlated strongly with the annual incidence 
of human cases related to this type of isolate (r = 0.91, 
p<0.0001) (Figure 1). This strongly signiﬁ  cant correlation 
held across time and within different Canadian provinces 
(Ontario, r = 0.93, p<0.01; Québec, r = 0.89, p = 0.01).
Changes in ceftiofur resistance alone did not explain 
a number of the temporal changes in exposure (12). For 
example, in Ontario, the decrease in the prevalence of re-
tail chicken contaminated with ceftiofur-resistant Salmo-
nella Heidelberg isolates during 2004–2008 (Figure 1) was 
linked to a decrease in ceftiofur resistance from 58% to 
14% (Table) and a decrease in the prevalence of Salmo-
nella Heidelberg in chicken from 61% to 15% of all Sal-
monella isolates. In Québec, the decrease in contamination 
of chicken with ceftiofur-resistant Salmonella Heidelberg 
strains from 2003 to 2004 (Figure 1) was related mainly 
to a decrease in the prevalence of Salmonella Heidelberg 
(from 71% to 48%) in chicken, whereas the decrease from 
2004 to 2006 was attributable mainly to a drop in ceftiofur 
resistance from 62% to 7% (Table). In British Columbia, 
the low level of chicken contamination with ceftiofur-re-
sistant Salmonella Heidelberg strains resulted mainly from 
the rarity of Salmonella Heidelberg (only 11% of all Sal-
monella in 2007–2008), and low exposure levels in Sas-
katchewan were related mainly to low ceftiofur resistance 
among Salmonella Heidelberg (Table).
Ceftiofur-Resistant E. coli Isolated from Retail Chicken
Retail chicken generally was more frequently contami-
nated with ceftiofur-resistant commensal E. coli than with 
ceftiofur-resistant Salmonella Heidelberg isolates (Figure 
1). The proportion of chicken contaminated with ceftiofur-
resistant  E. coli (Figure 1) closely followed changes in 
ceftiofur resistance (Table) because commensal E. coli was 
recovered from almost all (89%–100%) chicken samples 
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Figure 1. Prevalence of retail chicken contaminated with ceftiofur-
resistant  Escherichia coli and Salmonella enterica serovar 
Heidelberg and incidence of human infections from ceftiofur-
resistant Salmonella Heidelberg in Canada.Ceftiofur Resistance in Salmonella Heidelberg
collected. Exposure to ceftiofur-resistant E. coli strains 
appeared to have increased in recent years in Canada (Fig-
ure 1). In 2008, exposure to ceftiofur-resistant E. coli strains 
was highest in British Columbia and lowest in Québec.
Temporal Changes in Ceftiofur Resistance 
in the Province of Québec, 2003–2008
In 2003–2004, >60% of the chicken Salmonella 
Heidelberg isolates were ceftiofur resistant, and ceftiofur 
resistance among chicken E. coli and human Salmonella 
Heidelberg isolates varied from 30% to 40% (Figure 2). 
Ceftiofur resistance declined sharply immediately after the 
ﬁ  rst quarter of 2005 among chicken E. coli and Salmonel-
la Heidelberg isolates, and a similar decline began in the 
next quarter among human Salmonella Heidelberg isolates 
(Figure 2). This decline steadily continued until the end 
of 2006. As a result, the prevalence of ceftiofur resistance 
signiﬁ  cantly decreased from 2004 to 2006 among chicken 
(62% to 7%; p<0.001) and human (36% to 8%; p<0.0001) 
Salmonella Heidelberg isolates and chicken E. coli iso-
lates (34% to 6%; p<0.0001 [Table]). Then, from 2006 to 
2008, the prevalence of ceftiofur resistance signiﬁ  cantly 
increased among chicken E. coli isolates (6% to 18%; p 
= 0.002), and prevalence of ceftiofur resistance increased, 
but not signiﬁ  cantly, among Salmonella Heidelberg from 
chicken (7% to 18%; p = 0.32) and human (8% to 12%; p = 
0.41) isolates (Table).
Discussion
CIPARS data clearly indicate a temporal association 
between changing levels of contamination of retail chicken 
with ceftiofur-resistant Salmonella Heidelberg strains and 
incidence of ceftiofur-resistant Salmonella Heidelberg in-
fection in humans. This correlation is strong and applies to 
different regions of Canada. Our observation is consistent 
with published results from outbreak investigations and 
case-control studies suggesting that chicken products are a 
source of human infection with Salmonella Heidelberg in 
Canada (7,8).
Although humans potentially can become infected with 
ceftiofur-resistant Salmonella Heidelberg from sources oth-
er than chicken, chicken appears the most likely source in 
Canada. Ceftiofur-resistant Salmonella Heidelberg has never 
been reported among CIPARS porcine Salmonella of abat-
toir origin, and it has not been detected among retail pork, 
abattoir beef, or retail beef, in which Salmonella prevalence 
remains <2% (12). Data generated by National Antimicro-
bial Resistance Monitoring System retail surveillance in the 
United States indicated that 17% of Salmonella Heidelberg 
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Figure 2. Prevalence of ceftiofur resistance (moving average of the 
current quarter and the previous 2 quarters) among retail chicken 
Escherichia coli, and retail chicken and human clinical Salmonella 
enterica serovar Heidelberg isolates during 2003–2008 in Québec, 
Canada.
Table. Prevalence of ceftiofur resistance among human and retail chicken Salmonella serovar Heidelberg isolates and retail chicken 
Escherichia coli isolates from Canadian provinces surveyed during 2003–2008 
Prevalence of ceftiofur resistance, % (no. resistant isolates/total no. isolates tested)
Isolate/province 2003 2004 2005 2006 2007 2008
Human clinical Salmonella Heidelberg
  Québec 31 (52/167) 36 (42/116) 35 (37/106) 8 (8/96) 6 (4/63) 12 (8/65)
  Ontario 18 (31/172) 38 (70/185) 30 (42/140) 10 (12/122) 22 (21/94) 32 (7/22)
  Saskatchewan 0 (0/15) 7 (1/14) 0 (0/11) 0 (0/7)
 British  Columbia 23 (3/13) 19 (3/16)
Chicken retail Salmonella Heidelberg
  Québec 65 (13/20) 62 (18/29) 33 (4/12) 7 (1/14) 19 (6/32) 18 (7/38)
  Ontario 16 (3/19) 58 (19/33) 27 (3/11) 21 (3/14) 21 (9/42) 14 (3/21)
  Saskatchewan 0 (0/5) 13 (1/8) 0 (0/9) 8 (1/12)
 British  Columbia 50 (2/4) 67 (2/3)
Chicken retail E. coli
  Québec 32 (36/111) 34 (54/158) 25 (35/142) 6 (8/135) 13 (17/128) 18 (24/131)
  Ontario 18 (24/136) 21 (32/150) 17 (25/145) 22 (34/152) 22 (35/157) 24 (36/150)
  Saskatchewan 4 (3/82) 6 (5/85) 13 (10/75) 20 (18/92)
 British  Columbia 29 (12/42) 49 (34/70)RESEARCH
isolates recovered from ground turkey in 2006 were resistant 
to ceftiofur (13). CIPARS does not conduct ongoing surveil-
lance of retail turkey, and we cannot ignore the possibility 
that retail turkey could be a source of ceftiofur-resistant Sal-
monella Heidelberg for humans as well. However, turkey 
consumption in Canada (4.7 kg per capita) was much lower 
than chicken consumption (33.2 kg per capita) in 2007 (31). 
Lastly, Salmonella Heidelberg has been reported in clinical 
samples from various other animal species in Canada (12), 
and exposure to sick animals could potentially be another 
source of infection. However, ceftiofur resistance in clinical 
Salmonella Heidelberg isolates remains anecdotal in species 
other than chicken and turkey (12).
Drug use monitoring in chicken is nonexistent in 
Canada. However, research data indicate a high level of 
ceftiofur use in Québec hatcheries in 2003–2004, where 
at least 78% of the lots surveyed in Québec abattoirs (M. 
Boulianne et al., unpub. data) had received ceftiofur in ovo. 
During that same period, ceftiofur resistance among retail 
chicken Salmonella Heidelberg isolates were >60%. The 
rapid and important 82% (E. coli) and 89% (Salmonella 
Heidelberg) declines in ceftiofur resistance in Québec re-
tail chicken meat that followed in 2005–2006, as well as in 
Québec chicken E. coli and Salmonella isolates collected 
from passive surveillance of animal clinical isolates con-
ducted by the Ministère de l’Agriculture, des Pêcheries et 
de l’Alimentation du Québec (MAPAQ) (32), is consistent 
with an effective voluntary withdrawal in 2005 and 2006. 
In 2007, the Québec broiler industry announced a potential 
partial reinstitution of ceftiofur use to control omphalitis 
in young chicks, with the intention of using the drug on 
a rotational basis and limiting its use to no more than 6 
months per year (32). Again, CIPARS data from Québec 
retail chicken sampling in 2007–2008 demonstrating a 
reemergence of ceftiofur resistance among E. coli but at 
lower levels than in 2003–2004 are consistent with a par-
tial return to ceftiofur use. The simultaneous reduction (and 
reemergence) in ceftiofur resistance in both retail chicken 
E. coli and Salmonella Heidelberg isolates and in clini-
cal chicken E. coli and Salmonella isolates from MAPAQ 
surveillance support the hypothesis that the ﬂ  uctuations in 
ceftiofur resistance most likely were driven by a common 
exposure (or reduction of exposure) to ceftiofur in chicken 
hatcheries, rather than simply being secondary to the natu-
ral spread and disappearance of a ceftiofur-resistant clone 
unrelated to ceftiofur use.
Although Ontario hatcheries had never announced 
an ofﬁ  cial withdrawal of ceftiofur use, a drop in ceftiofur 
resistance also was observed among chicken Salmonella 
Heidelberg isolates in Ontario in 2005. Although some ar-
gue that this proves the absence of an association between 
ceftiofur use and ceftiofur resistance in broiler chicken, 
movement of hatching eggs, broiler chicks (mostly from 
Québec to Ontario), and retail chicken meat between these 
2 provinces could explain some of the similarities among 
Salmonella Heidelberg isolates in Ontario and Québec 
(33). The withdrawal in Québec might also have led Ontar-
io broiler chicken hatcheries to temporarily decrease their 
use of ceftiofur in 2005.
In the absence of reliable comprehensive drug use in-
formation in the broiler chicken industry, we use resistance 
in commensal E. coli as a surrogate measure of the level 
of drug use (34). The high prevalence of ceftiofur resis-
tance among E. coli isolates from British Columbia (almost 
half of the isolates in 2008 in that province), the increasing 
prevalence of resistance measured in Saskatchewan, and 
the 22% ceftiofur resistance among chicken E. coli isolates 
from Ontario when ceftiofur resistance prevalence was at 
its lowest level in Québec in 2006, indicates that ceftiofur 
use is unlikely to be restricted to the province of Québec. 
Lastly, in ovo ceftiofur use has also been reported in US 
chicken hatcheries (35).
Coselection of resistance to cephalosporins by expo-
sure to other antimicrobials or to chemicals in the agricul-
tural environment has been suggested as a confounding 
factor for the increase in observed resistance. Giles et al. 
(36) report the presence of the sugE gene on the same ele-
ment as the blaCMY-2 gene in Salmonella, but the capacity 
of this gene to effectively confer resistance to quaternary 
ammonium compounds and provide coselection remains 
uncertain.
The levels of contamination of retail chicken with 
ceftiofur-resistant  E. coli represent an additional con-
cern. No selective media for ceftiofur-resistant strains 
was used, and the level of contamination of retail chicken 
with ceftiofur-resistant E. coli (and Salmonella Heidel-
berg) strains was most likely underestimated. Although 
this study describes exposure to commensal E. coli, such 
strains occasionally may cause infections in predisposed 
humans. In addition, the species E. coli includes a variety 
of strains commonly pathogenic for humans, and some 
strains from the normal ﬂ  ora of animals may carry a vari-
ety of virulence determinants that increase their potential 
for causing disease in humans (37). Poppe et al. (38) also 
demonstrated experimentally the acquisition of resistance 
to extended-spectrum cephalosporins by Salmonella sero-
var Newport from E. coli strains by conjugation in poultry 
intestinal tracts. In addition, molecular characterization of 
plasmids from ﬁ  eld isolates demonstrates that identical 
blaCMY-2 plasmids can be found in both Salmonella and E. 
coli from the same chicken (P. Boerlin et al., unpub. data). 
Because the blaCMY-2 gene is horizontally transferable and 
is frequently observed in ceftiofur-resistant isolates of 
chicken origin, chicken could potentially be a reservoir 
of this gene for human pathogens, including Salmonella 
and others.
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Except for anecdotal information, little information is 
available about drugs used by broiler chicken hatcheries 
and growers in Canada. The absence of on-farm drug use 
monitoring data prevents us from fully determining the 
effect of subtle changes in the level of use of ceftiofur (or 
other drugs) on resistance among bacteria recovered from 
chickens in Canada. Surveillance data from turkey or other 
nonsurveyed commodities would be useful to adequately 
quantify the contribution of each commodity to the over-
all number of cases related to ceftiofur-resistant Salmo-
nella Heidelberg in humans. The impact of disinfectants 
used by the broiler industry at the farm or processing level 
on the selection of ceftiofur-resistant strains also needs 
to be assessed. Lastly, CIPARS is planning a burden-of-
illness study to measure the impact of extended-spectrum 
cephalosporin resistance in Salmonella Heidelberg on hu-
man health.
Efforts undertaken by Québec chicken hatcheries to 
voluntarily withdraw use of ceftiofur in 2005–2006 coin-
cided with a markedly reduced prevalence of ceftiofur-re-
sistant Salmonella Heidelberg in retail chicken. This drop 
also effectively reduced the number of ceftiofur-resistant 
Salmonella Heidelberg infections in humans in this prov-
ince during the same period. This reduction suggests that 
control of resistance to extended-spectrum cephalosporins 
is possible by managing ceftiofur use at the hatchery level. 
The partial reintroduction of ceftiofur use in Québec chick-
en hatcheries in 2007 with increasing rates of ceftiofur re-
sistance after reintroduction, and indications that ceftiofur 
is used for the same purpose in other Canadian provinces, 
is of high concern. An increasing level of exposure to E. 
coli strains carrying horizontally transferable genes confer-
ring resistance to extended-cephalosporins complicates the 
situation. To ensure the continued effectiveness of extend-
ed-spectrum cephalosporins to treat serious human infec-
tions, multidisciplinary efforts are needed to scrutinize, and 
where appropriate, limit use of ceftiofur in Canadian food 
animal production, particularly in chicken. 
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